Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Discovery of Potential Flavonoid Inhibitors Against COVID-19 3CL Proteinase Based on Virtual Screening Strategy
Zhongren Xu, Lixiang Yang, Xinghao Zhang, et al.
Frontiers in Molecular Biosciences (2020) Vol. 7
Open Access | Times Cited: 66

Showing 1-25 of 66 citing articles:

Artificial intelligence to deep learning: machine intelligence approach for drug discovery
Rohan Gupta, Devesh Srivastava, Mehar Sahu, et al.
Molecular Diversity (2021) Vol. 25, Iss. 3, pp. 1315-1360
Open Access | Times Cited: 861
Flavonoids are promising safe therapy against COVID-19
Moza Mohamed Alzaabi, Rania Hamdy, Naglaa S. Ashmawy, et al.
Phytochemistry Reviews (2021) Vol. 21, Iss. 1, pp. 291-312
Open Access | Times Cited: 133
Drug Repurposing Strategy (DRS): Emerging Approach to Identify Potential Therapeutics for Treatment of Novel Coronavirus Infection
Biswa Mohan Sahoo, B. V. V. Ravi Kumar, J. Sruti, et al.
Frontiers in Molecular Biosciences (2021) Vol. 8
Open Access | Times Cited: 103
Synthesis of New Organoselenium-Based Succinanilic and Maleanilic Derivatives and In Silico Studies as Possible SARS-CoV-2 Main Protease Inhibitors
Saad Shaaban, Yasair S. Al-Faiyz, Ghayah M. Alsulaim, et al.
Inorganics (2023) Vol. 11, Iss. 8, pp. 321-321
Open Access | Times Cited: 51
Evolving scenario of big data and Artificial Intelligence (AI) in drug discovery
Manish Tripathi, Abhigyan Nath, T.P. Singh, et al.
Molecular Diversity (2021) Vol. 25, Iss. 3, pp. 1439-1460
Open Access | Times Cited: 91
Rutin Is a Low Micromolar Inhibitor of SARS-CoV-2 Main Protease 3CLpro: Implications for Drug Design of Quercetin Analogs
Bruno Rizzuti, Fedora Grande, Filomena Conforti, et al.
Biomedicines (2021) Vol. 9, Iss. 4, pp. 375-375
Open Access | Times Cited: 74
Artificial Intelligence in Surveillance, Diagnosis, Drug Discovery and Vaccine Development against COVID-19
Gunjan Arora, Jayadev Joshi, Rahul Shubhra Mandal, et al.
Pathogens (2021) Vol. 10, Iss. 8, pp. 1048-1048
Open Access | Times Cited: 73
Halogenated Baicalein as a Promising Antiviral Agent toward SARS-CoV-2 Main Protease
Kowit Hengphasatporn, Patcharin Wilasluck, Peerapon Deetanya, et al.
Journal of Chemical Information and Modeling (2022) Vol. 62, Iss. 6, pp. 1498-1509
Closed Access | Times Cited: 55
A contemporary review on the important role of in silico approaches for managing different aspects of COVID-19 crisis
Mohammad Moradi, Reza Golmohammadi, Ali Najafi, et al.
Informatics in Medicine Unlocked (2022) Vol. 28, pp. 100862-100862
Open Access | Times Cited: 51
Computer especially AI-assisted drug virtual screening and design in traditional Chinese medicine
Yumeng Lin, You Zhang, Dongyang Wang, et al.
Phytomedicine (2022) Vol. 107, pp. 154481-154481
Closed Access | Times Cited: 47
Flavonols and dihydroflavonols inhibit the main protease activity of SARS-CoV-2 and the replication of human coronavirus 229E
Yue Zhu, Frank Scholle, Samantha C. Kisthardt, et al.
Virology (2022) Vol. 571, pp. 21-33
Open Access | Times Cited: 37
Flavonoids as potential phytotherapeutics to combat cytokine storm in SARS‐CoV‐2
Abhishek Gour, Diksha Manhas, Swarnendu Bag, et al.
Phytotherapy Research (2021) Vol. 35, Iss. 8, pp. 4258-4283
Open Access | Times Cited: 46
Comprehensive virtual screening of 4.8 k flavonoids reveals novel insights into allosteric inhibition of SARS-CoV-2 MPRO
Gabriel Jiménez-Avalos, A. Paula Vargas-Ruiz, Nicolás E. Delgado-Pease, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 40
Identification of Potential Flavonoid Inhibitors of the SARS-CoV-2 Main Protease 6YNQ: A Molecular Docking Study
Sumit Arora, Govind K. Lohiya, Keshav S. Moharir, et al.
Digital Chinese Medicine (2020) Vol. 3, Iss. 4, pp. 239-248
Open Access | Times Cited: 39
Interaction of 8-anilinonaphthalene-1-sulfonate with SARS-CoV-2 main protease and its application as a fluorescent probe for inhibitor identification
Peerapon Deetanya, Kowit Hengphasatporn, Patcharin Wilasluck, et al.
Computational and Structural Biotechnology Journal (2021) Vol. 19, pp. 3364-3371
Open Access | Times Cited: 36
Jusanin, a New Flavonoid from Artemisia commutata with an In Silico Inhibitory Potential against the SARS-CoV-2 Main Protease
E. M. Suleimen, Rani Alphonsa Jose, Raigul N. Suleimen, et al.
Molecules (2022) Vol. 27, Iss. 5, pp. 1636-1636
Open Access | Times Cited: 25
Rutin: A Potential Antiviral for Repurposing as a SARS-CoV-2 Main Protease (Mpro) Inhibitor
Pawan K. Agrawal, Chandan Agrawal, Gerald Blunden
Natural Product Communications (2021) Vol. 16, Iss. 4
Open Access | Times Cited: 31
Engineering of 2D nanomaterials to trap and kill SARS-CoV-2: a new insight from multi-microsecond atomistic simulations
Mohammad Khedri, Reza Maleki, Mohammad Dahri, et al.
Drug Delivery and Translational Research (2021) Vol. 12, Iss. 6, pp. 1408-1422
Open Access | Times Cited: 29
New perspectives on natural flavonoids on COVID‐19‐induced lung injuries
Fernanda Paula Roncon Santana, Fernanda Thevenard, Kaio S. Gomes, et al.
Phytotherapy Research (2021) Vol. 35, Iss. 9, pp. 4988-5006
Open Access | Times Cited: 28
Flavonoids from Siparuna cristata as Potential Inhibitors of SARS-CoV-2 Replication
Carla Monteiro Leal, Suzana Guimarães Leitão, Romain Sausset, et al.
Revista Brasileira de Farmacognosia (2021) Vol. 31, Iss. 5, pp. 658-666
Open Access | Times Cited: 27
Exploring the inhibitory potential of Saussurea costus and Saussurea involucrata phytoconstituents against the Spike glycoprotein receptor binding domain of SARS-CoV-2 Delta (B.1.617.2) variant and the main protease (Mpro) as therapeutic candidates, using Molecular docking, DFT, and ADME/Tox studies
Selma Houchi, Zakia Messasma
Journal of Molecular Structure (2022) Vol. 1263, pp. 133032-133032
Open Access | Times Cited: 19
Computational investigation on the antioxidant activities and on the Mpro SARS-CoV-2 non-covalent inhibition of isorhamnetin
Maciej Spiegel, Giada Ciardullo, Tiziana Marino, et al.
Frontiers in Chemistry (2023) Vol. 11
Open Access | Times Cited: 10
Sub-Micromolar Inhibition of SARS-CoV-2 3CLpro by Natural Compounds
Bruno Rizzuti, Laura Ceballos-Laita, David Ortega-Alarcón, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 9, pp. 892-892
Open Access | Times Cited: 23
Discovery of Diverse Natural Products as Inhibitors of SARS-CoV-2 Mpro Protease through Virtual Screening
J. Rubio, Ana Jiménez-Alesanco, Laura Ceballos-Laita, et al.
Journal of Chemical Information and Modeling (2021) Vol. 61, Iss. 12, pp. 6094-6106
Open Access | Times Cited: 23
Semi-Synthesis of N-Aryl Amide Analogs of Piperine from Piper nigrum and Evaluation of Their Antitrypanosomal, Antimalarial, and Anti-SARS-CoV-2 Main Protease Activities
Rattanaporn Wansri, Aye Chan Khine Lin, Jutharat Pengon, et al.
Molecules (2022) Vol. 27, Iss. 9, pp. 2841-2841
Open Access | Times Cited: 17
Page 1 - Next Page

Scroll to top